Intrinsic resistance to tyrosine kinase inhibitors is associated with poor clinical outcome in metastatic renal cell carcinomaJonas Busch, Viktor Grünwald, Christoph Seidel et al.|BMC Cancer|2011Cited by 54
Expression Profile of the Polycomb Group Protein Enhancer of Zeste Homologue 2 and its Prognostic Relevance in Renal Cell CarcinomaStefan Hinz, Carsten Kempkensteffen, Steffen Weikert et al.|The Journal of Urology|2009Cited by 50
Expression levels of the mitochondrial IAP antagonists Smac/DIABLO and Omi/HtrA2 in clear-cell renal cell carcinomas and their prognostic valueCarsten Kempkensteffen, Steffen Weikert, Stefan Hinz et al.|Journal of Cancer Research and Clinical Oncology|2007Cited by 46
Sequence Therapy in Patients with Metastatic Renal Cell Carcinoma: Comparison of Common Targeted Treatment Options Following Failure of Receptor Tyrosine Kinase InhibitorsJonas Busch, Steffen Weikert, Christoph Seidel et al.|European Urology|2011Cited by 45
Expression of the Apoptosis Inhibitor Livin in Renal Cell Carcinomas: Correlations with Pathology and OutcomeCarsten Kempkensteffen, Steffen Weikert, Stefan Hinz et al.|Tumor Biology|2007Cited by 43